The 13th Annual Research Day

Thanks to all of the faculty, staff, and students who participated in Research Day,
your participation made this year's event the best ever. The 13th Annual Research Day was very successful having showcased the growth and depth of our research with more than 60 posters authored by interdisciplinary faculty and students.

Touro's Annual Research Day provides an opportunity for faculty, staff, and students to share their research efforts with the campus community. The program encourages the development of joint research projects and increases the student body awareness of the quality and range of research conducted on campus.

This year’s 13th Annual Research Day (April 30, 2014) hosted major keynote speaker,
Dr. Ira Schwartz who is a Professor and Chairman of Microbiology and Immunology at New York Medical College. His presentation was titled, "Even Bacteria Must Watch Their Carbs: Lyme Disease, Intermediary Metabolism& the Borrelia burgdorferi Enzootic Cycle.

Research Day


Lander Hall, Lecture Hall A
(Lunch will be provided)

12:30-1:00- Lunch & Introductions

1:00-2:00- Keynote Speaker:

Ira Schwartz, Ph.D.
Professor and Chairman of Microbiology and Immunology

2:00-2:30- Inhibition of HIV Fusion by Proteins and Small Molecules, Joseph Walsh PhD

2:30-3:00- The Conversion of Sugar to Fat: The Biochemical Pathway Responsible for Cardiovascular, Nonalcoholic Fatty Liver and Diabetes?, Jean-Marc Schwarz PhD

Farragut Inn Ballroom

3:00-6:00- Poster Session & Reception with wine, hors d'oeuvres and camaraderie.

A Brief Bio on our Keynote Speaker: Dr. Ira Schwarz

Dr. Ira Schwartz is Professor and Chairman of Microbiology and Immunology at New York Medical College since 2002. He received his Ph.D. in Biochemistry from the City University of New York in 1973 and studied ribosome structure and function during a two year postdoctoral fellowship at the Roche Institute of Molecular Biology. He was an assistant professor of biochemistry at the University of Massachusetts (Amherst) from 1975-80 before joining the biochemistry faculty at New York Medical College in 1980. In addition to his primary appointment, Schwartz is also a professor of medicine and biochemistry and molecular biology at the college. Dr. Schwartz was recipient of a Sinsheimer Scholar Award from the Alexandrine and Alexander L. Sinsheimer Foundation in 1981. He is a member of the editorial boards of Infection and Immunity and Emerging Infectious Diseases, has served on numerous NIH and American Heart Association review panels and is an external advisory board member for the NIH-funded INBRE program for the state of Oklahoma.

Dr. Schwartz was awarded his first grant in 1975 to study initiation of protein synthesis in E. coli and his research has been continuously funded since that time; his work is currently supported by grants from NIH and CDC. He is author of more than 130 publications in the peer-reviewed literature. Research activities in his laboratory focus on emerging tick-borne infectious diseases, primarily Lyme disease and human granulocytic anaplasmosis. Projects include development of molecular diagnostics, determination of pathogen prevalence in natural tick and wildlife populations, characterization of heterogeneous populations of Borrelia burgdorferi in nature and Lyme disease patients and mechanisms of B. burgdorferi pathogenesis. His laboratory was one of the first to apply molecular analysis to the study of B. burgdorferi. Among early contributions were sequencing of the B. burgdorferi ribosomal RNA operon (before the genome was sequenced) and utilizing this information to develop diagnostic assays for detection of the spirochete in Lyme disease patients, wildlife and ticks. Dr. Schwartz spearheaded a group of eight investigators who collaborated on producing B. burgdorferi whole genome membrane arrays and his laboratory subsequently constructed oligonucleotide arrays that have been provided to many other investigators. Their use has facilitated numerous studies on transcriptional regulation in B. burgdorferi. His group also developed a PCR-based assay for typing spirochetal isolates which led to the seminal observation that B. burgdorferi genotype predicted its capacity for hematogenous dissemination. These investigations led to current studies applying genomic and genetic approaches with the goal of identifying genes that might be responsible for this differential pathogenicity.



















Last Updated: 5/15/14